{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:15:00Z","timestamp":1762272900955},"reference-count":121,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The vascular endothelial growth factor (VEGF) family plays a major role in tumors and\nophthalmic diseases. However, increasingly more data reported its potential in regulating lipids.\nWith its biological functions mainly expressed in lymphatic vessels, some factors in the families,\nlike VEGF-A and VEGF-C, have been proved to regulate intestinal absorption of lipids by affecting\nchylous ducts. Other effects, including regulating lipoprotein lipase (LPL), endothelial lipase (EL),\nand recombinant syndecan 1 (SDC1), have also been confirmed. However, given the scant-related\nstudies, further research should be conducted to examine the concrete mechanisms and provide\npragmatic ways to apply them in the clinic. The VEGF family may treat dyslipidemia in specific\nways that are different from common methods and concurrently contribute to the treatment of other\nmetabolic diseases, like diabetes and obesity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201023666220506105026","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:27:19Z","timestamp":1651919239000},"page":"253-265","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Role of VEGF Family in Lipid Metabolism"],"prefix":"10.2174","volume":"24","author":[{"given":"Yan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"},{"name":"Beijing University of Chinese Medicine, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueping","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglin","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanming","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhen","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2016.02.006","volume":"248","author":"Pan L.","year":"2016","unstructured":"Pan L.; Yang Z.; Wu Y.; Yin R.X.; Liao Y.; Wang J.; Gao B.; Zhang L.; The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis 2016,248,2-9","journal-title":"Atherosclerosis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC201712050","volume":"167","author":"Kopin L.","year":"2017","unstructured":"Kopin L.; Lowenstein C.; Dyslipidemia. Ann Intern Med 2017,167(11),ITC81-ITC96","journal-title":"Ann Intern Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1177\/0148607115595974","volume":"39","author":"Kalish B.T.","year":"2015","unstructured":"Kalish B.T.; Fell G.L.; Nandivada P.; Puder M.; Clinically relevant mechanisms of lipid synthesis, transport, and storage. JPEN J Parenter Enteral Nutr 2015,39(1)(Suppl.),8S-17S","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"738325","DOI":"10.3389\/fcvm.2021.738325","volume":"8","author":"Zhou Y.","year":"2021","unstructured":"Zhou Y.; Zhu X.; Cui H.; Shi J.; Yuan G.; Shi S.; Hu Y.; The role of the VEGF family in coronary heart disease. Front Cardiovasc Med 2021,8,738325","journal-title":"Front Cardiovasc Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/978-1-0716-0163-1_16","volume":"2089","author":"Gunasekaran B.","year":"2020","unstructured":"Gunasekaran B.; Shukor M.Y.; HMG-CoA reductase as target for drug development. Methods Mol Biol 2020,2089,245-250","journal-title":"Methods Mol Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","volume":"120","author":"Oesterle A.","year":"2017","unstructured":"Oesterle A.; Laufs U.; Liao J.K.; Pleiotropic effects of statins on the cardiovascular system. Circ Res 2017,120(1),229-243","journal-title":"Circ Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e1900378","DOI":"10.1002\/ardp.201900378","volume":"353","author":"Ozalp L.","year":"2020","unstructured":"Ozalp L.; Dan\u0131&#x15F; &#xD6;.; Yuce-Dursun B.; Demir S.; G&#xFC;nd&#xFC;z C.; Ogan A.; Investigation of HMG-CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives. Arch Pharm (Weinheim) 2020,353(10),e1900378","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jcb.25608","volume":"118","author":"Suganya S.","year":"2017","unstructured":"Suganya S.; Nandagopal B.; Anbarasu A.; Natural inhibitors of HMG-CoA reductase-an in silico approach through molecular docking and simulation studies. J Cell Biochem 2017,118(1),52-57","journal-title":"J Cell Biochem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/nu12103077","volume":"12","author":"Ibrahim A.","year":"2020","unstructured":"Ibrahim A.; Shafie N.H.; Mohd Esa N.; Shafie S.R.; Bahari H.; Abdullah M.A.; Mikania micrantha extract inhibits HMG-CoA reductase and ACAT2 and ameliorates hypercholesterolemia and lipid peroxidation in high cholesterol-fed rats. Nutrients 2020,12(10),12","journal-title":"Nutrients"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/1573399814666180924113442","volume":"15","author":"Nabi R.","year":"2019","unstructured":"Nabi R.; Alvi S.S.; Saeed M.; Ahmad S.; Khan M.S.; Glycation and HMG-CoA reductase inhibitors: Implication in diabetes and associated complications. Curr Diabetes Rev 2019,15(3),213-223","journal-title":"Curr Diabetes Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3945\/jn.110.127027","volume":"141","author":"Reena M.B.","year":"2011","unstructured":"Reena M.B.; Gowda L.R.; Lokesh B.R.; Enhanced hypocholesterolemic effects of interesterified oils are mediated by upregulating LDL receptor and cholesterol 7-&#x3B1;- hydroxylase gene expression in rats. J Nutr 2011,141(1),24-30","journal-title":"J Nutr"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.physiol.64.082201.100300","volume":"64","author":"Meier P.J.","year":"2002","unstructured":"Meier P.J.; Stieger B.; Bile salt transporters. Annu Rev Physiol 2002,64(1),635-661","journal-title":"Annu Rev Physiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1007\/s11695-020-04506-3","volume":"30","author":"Ueno T.","year":"2020","unstructured":"Ueno T.; Tanaka N.; Imoto H.; Maekawa M.; Kohyama A.; Watanabe K.; Motoi F.; Kamei T.; Unno M.; Naitoh T.; Mechanism of bile acid reabsorption in the biliopancreatic limb after duodenal-jejunal bypass in rats. Obes Surg 2020,30(7),2528-2537","journal-title":"Obes Surg"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"G303","DOI":"10.1152\/ajpgi.00385.2019","volume":"319","author":"Cai J.","year":"2020","unstructured":"Cai J.; Wang Z.; Chen G.; Li D.; Liu J.; Hu H.; Qin J.; Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstone. Am J Physiol Gastrointest Liver Physiol 2020,319(3),G303-G308","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"Chiang J.Y.","year":"2013","unstructured":"Chiang J.Y.; Bile acid metabolism and signaling. Compr Physiol 2013,3(3),1191-1212","journal-title":"Compr Physiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1074\/jbc.RA119.011913","volume":"295","author":"Takahashi S.","year":"2020","unstructured":"Takahashi S.; Luo Y.; Ranjit S.; Xie C.; Libby A.E.; Orlicky D.J.; Dvornikov A.; Wang X.X.; Myakala K.; Jones B.A.; Bhasin K.; Wang D.; McManaman J.L.; Krausz K.W.; Gratton E.; Ir D.; Robertson C.E.; Frank D.N.; Gonzalez F.J.; Levi M.; Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice. J Biol Chem 2020,295(14),4733-4747","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mnfr.201700696","volume":"62","author":"Huang J.","year":"2018","unstructured":"Huang J.; Feng S.; Liu A.; Dai Z.; Wang H.; Reuhl K.; Lu W.; Yang C.S.; Green tea polyphenol EGCG alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice. Mol Nutr Food Res 2018,62(4),62","journal-title":"Mol Nutr Food Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1096\/fj.201600465R","volume":"30","author":"Gunness P.","year":"2016","unstructured":"Gunness P.; Michiels J.; Vanhaecke L.; De Smet S.; Kravchuk O.; Van de Meene A.; Gidley M.J.; Reduction in circulating bile acid and restricted diffusion across the intestinal epithelium are associated with a decrease in blood cholesterol in the presence of oat &#x3B2;-glucan. FASEB J 2016,30(12),4227-4238","journal-title":"FASEB J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"116643","DOI":"10.1016\/j.lfs.2019.116643","volume":"232","author":"Dolezelova E.","year":"2019","unstructured":"Dolezelova E.; Sa I.C.I.; Prasnicka A.; Hroch M.; Hyspler R.; Ticha A.; Lastuvkova H.; Cermanova J.; Pericacho M.; Visek J.; Lasticova M.; Micuda S.; Nachtigal P.; High soluble endoglin levels regulate cholesterol homeostasis and bile acids turnover in the liver of transgenic mice. Life Sci 2019,232,116643","journal-title":"Life Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12986-018-0267-x","volume":"15","author":"Li H.","year":"2018","unstructured":"Li H.; Liu Y.; Zhang X.; Xu Q.; Zhang Y.; Xue C.; Guo C.; Medium-chain fatty acids decrease serum cholesterol via reduction of intestinal bile acid reabsorption in C57BL\/6J mice. Nutr Metab (Lond) 2018,15(1),37","journal-title":"Nutr Metab (Lond)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e13548","DOI":"10.1111\/jfbc.13548","volume":"45","author":"Wang R.","year":"2021","unstructured":"Wang R.; You Y.M.; Liu X.; Effect of Zanthoxylum alkylamides on lipid metabolism and its mechanism in rats fed with a high-fat diet. J Food Biochem 2021,45(1),e13548","journal-title":"J Food Biochem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"104631","DOI":"10.1016\/j.phrs.2020.104631","volume":"152","author":"Liu J.","year":"2020","unstructured":"Liu J.; Li Y.; Sun C.; Liu S.; Yan Y.; Pan H.; Fan M.; Xue L.; Nie C.; Zhang H.; Qian H.; Ying H.; Wang L.; Geniposide reduces cholesterol accumulation and increases its excretion by regulating the FXR-mediated liver-gut crosstalk of bile acids. Pharmacol Res 2020,152,104631","journal-title":"Pharmacol Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/MOL.0000000000000297","volume":"27","author":"Olivecrona G.","year":"2016","unstructured":"Olivecrona G.; Role of lipoprotein lipase in lipid metabolism. Curr Opin Lipidol 2016,27(3),233-241","journal-title":"Curr Opin Lipidol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","volume":"61","author":"Kei A.A.","year":"2012","unstructured":"Kei A.A.; Filippatos T.D.; Tsimihodimos V.; Elisaf M.S.; A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism 2012,61(7),906-921","journal-title":"Metabolism"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11883-019-0791-9","volume":"21","author":"Taskinen M.R.","year":"2019","unstructured":"Taskinen M.R.; Packard C.J.; Bor&#xE9;n J.; Emerging evidence that ApoC-III inhibitors provide novel options to reduce the residual CVD. Curr Atheroscler Rep 2019,21(8),27","journal-title":"Curr Atheroscler Rep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.4070\/kcj.2018.0343","volume":"48","author":"Reiner &#x17D;.","year":"2018","unstructured":"Reiner &#x17D;.; Triglyceride-rich lipoproteins and novel targets for anti-atherosclerotic therapy. Korean Circ J 2018,48(12),1097-1119","journal-title":"Korean Circ J"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/DDDT.S224771","volume":"14","author":"Esan O.","year":"2020","unstructured":"Esan O.; Wierzbicki A.S.; Volanesorsen in the treatment of familial chylomicronemia syndrome or hypertriglyceridaemia: Design, development and place in therapy. Drug Des Devel Ther 2020,14,2623-2636","journal-title":"Drug Des Devel Ther"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/01.CIR.98.19.2088","volume":"98","author":"Staels B.","year":"1998","unstructured":"Staels B.; Dallongeville J.; Auwerx J.; Schoonjans K.; Leitersdorf E.; Fruchart J.C.; Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998,98(19),2088-2093","journal-title":"Circulation"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12944-016-0286-4","volume":"15","author":"Backes J.","year":"2016","unstructured":"Backes J.; Anzalone D.; Hilleman D.; Catini J.; The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids Health Dis 2016,15(1),118","journal-title":"Lipids Health Dis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrendo.2017.119","volume":"13","author":"Kersten S.","year":"2017","unstructured":"Kersten S.; Angiopoietin-like 3 in lipoprotein metabolism. Nat Rev Endocrinol 2017,13(12),731-739","journal-title":"Nat Rev Endocrinol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0272-6386(12)70173-7","volume":"22","author":"Illingworth D.R.","year":"1993","unstructured":"Illingworth D.R.; Lipoprotein metabolism. Am J Kidney Dis 1993,22(1),90-97","journal-title":"Am J Kidney Dis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.metabol.2015.05.002","volume":"64","author":"Ganji S.H.","year":"2015","unstructured":"Ganji S.H.; Kashyap M.L.; Kamanna V.S.; Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. Metabolism 2015,64(9),982-990","journal-title":"Metabolism"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MOL.0b013e3283613a68","volume":"24","author":"Kamanna V.S.","year":"2013","unstructured":"Kamanna V.S.; Ganji S.H.; Kashyap M.L.; Recent advances in niacin and lipid metabolism. Curr Opin Lipidol 2013,24(3),239-245","journal-title":"Curr Opin Lipidol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22063144","volume":"22","author":"Basiak M.","year":"2021","unstructured":"Basiak M.; Kosowski M.; Cyrnek M.; Bu\u0142dak \u0141.; Malig\u0142&#xF3;wka M.; Machnik G.; Okopie\u0144 B.; Pleiotropic effects of PCSK-9 inhibitors. Int J Mol Sci 2021,22(6),22","journal-title":"Int J Mol Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2147\/TCRM.S230592","volume":"16","author":"Kosmas C.E.","year":"2020","unstructured":"Kosmas C.E.; Mu&#xF1;oz Estrella A.; Skavdis A.; Pe&#xF1;a Genao E.; Martinez I.; Guzman E.; Inclisiran for the treatment of cardiovascular disease: A short review on the emerging data and therapeutic potential. Ther Clin Risk Manag 2020,16,1031-1037","journal-title":"Ther Clin Risk Manag"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MOL.0000000000000084","volume":"25","author":"Hussain M.M.","year":"2014","unstructured":"Hussain M.M.; Intestinal lipid absorption and lipoprotein formation. Curr Opin Lipidol 2014,25(3),200-206","journal-title":"Curr Opin Lipidol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2165\/00003088-200544050-00002","volume":"44","author":"Kosoglou T.","year":"2005","unstructured":"Kosoglou T.; Statkevich P.; Johnson-Levonas A.O.; Paolini J.F.; Bergman A.J.; Alton K.B.; Ezetimibe: A review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 2005,44(5),467-494","journal-title":"Clin Pharmacokinet"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ejphar.2015.05.060","volume":"762","author":"Alqahtani S.","year":"2015","unstructured":"Alqahtani S.; Qosa H.; Primeaux B.; Kaddoumi A.; Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition. Eur J Pharmacol 2015,762,263-269","journal-title":"Eur J Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/2047487319870007","volume":"27","author":"Kolovou G.","year":"2020","unstructured":"Kolovou G.; Diakoumakou O.; Kolovou V.; Fountas E.; Stratakis S.; Zacharis E.; Liberopoulos E.N.; Matsouka F.; Tsoutsinos A.; Mastorakou I.; Katsikas T.; Mavrogeni S.; Hatzigeorgiou G.; Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia. Eur J Prev Cardiol 2020,27(2),157-165","journal-title":"Eur J Prev Cardiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1701329","volume":"377","author":"Graham M.J.","year":"2017","unstructured":"Graham M.J.; Lee R.G.; Brandt T.A.; Tai L.J.; Fu W.; Peralta R.; Yu R.; Hurh E.; Paz E.; McEvoy B.W.; Baker B.F.; Pham N.C.; Digenio A.; Hughes S.G.; Geary R.S.; Witztum J.L.; Crooke R.M.; Tsimikas S.; Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides. N Engl J Med 2017,377(3),222-232","journal-title":"N Engl J Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-0716-0771-8_5","volume":"2176","author":"Aslesh T.","year":"2020","unstructured":"Aslesh T.; Yokota T.; Development of antisense oligonucleotide gapmers for the treatment of dyslipidemia and lipodystrophy. Methods Mol Biol 2020,2176,69-85","journal-title":"Methods Mol Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14797\/mdcj-15-1-62","volume":"15","author":"De Giorgi M.","year":"2019","unstructured":"De Giorgi M.; Lagor W.R.; Gene delivery in lipid research and therapies. Methodist DeBakey Cardiovasc J 2019,15(1),62-69","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/cvr\/cvt148","volume":"99","author":"Heinonen S.E.","year":"2013","unstructured":"Heinonen S.E.; Kivel&#xE4; A.M.; Huusko J.; Dijkstra M.H.; Gurzeler E.; M&#xE4;kinen P.I.; Lepp&#xE4;nen P.; Olkkonen V.M.; Eriksson U.; Jauhiainen M.; Yl&#xE4;-Herttuala S.; The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. Cardiovasc Res 2013,99(4),716-723","journal-title":"Cardiovasc Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2337\/db12-1032","volume":"62","author":"Hodson L.","year":"2013","unstructured":"Hodson L.; Humphreys S.M.; Karpe F.; Frayn K.N.; Metabolic signatures of human adipose tissue hypoxia in obesity. Diabetes 2013,62(5),1417-1425","journal-title":"Diabetes"},{"key":"ref=45","first-page":"9485398","volume":"2020","author":"Wang L.","year":"2020","unstructured":"Wang L.; Wu H.; Xiong L.; Liu X.; Yang N.; Luo L.; Qin T.; Zhu X.; Shen Z.; Jing H.; Chen J.; Quercetin downregulates cyclooxygenase-2 expression and HIF-1alpha\/VEGF signaling-related angiogenesis in a mouse model of abdominal aortic aneurysm. BioMed Res Int 2020,2020,9485398","journal-title":"BioMed Res Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2012.12.010","volume":"17","author":"Sung H.K.","year":"2013","unstructured":"Sung H.K.; Doh K.O.; Son J.E.; Park J.G.; Bae Y.; Choi S.; Nelson S.M.; Cowling R.; Nagy K.; Michael I.P.; Koh G.Y.; Adamson S.L.; Pawson T.; Nagy A.; Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis. Cell Metab 2013,17(1),61-72","journal-title":"Cell Metab"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jnutbio.2009.05.004","volume":"21","author":"G&#xF3;mez-Ambrosi J.","year":"2010","unstructured":"G&#xF3;mez-Ambrosi J.; Catal&#xE1;n V.; Rodr&#xED;guez A.; Ram&#xED;rez B.; Silva C.; Gil M.J.; Salvador J.; Fr&#xFC;hbeck G.; Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem 2010,21(8),774-780","journal-title":"J Nutr Biochem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12906-017-1670-y","volume":"17","author":"Zeinalian R.","year":"2017","unstructured":"Zeinalian R.; Farhangi M.A.; Shariat A.; Saghafi-Asl M.; The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: A randomized double blinded placebo controlled trial. BMC Complement Altern Med 2017,17(1),225","journal-title":"BMC Complement Altern Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"10003","DOI":"10.1021\/acs.jafc.0c04386","volume":"68","author":"Chen S.","year":"2020","unstructured":"Chen S.; Wang R.; Cheng M.; Wei G.; Du Y.; Fan Y.; Li J.; Li H.; Deng Z.; Serum cholesterol-lowering activity of &#x3B2;-sitosterol laurate is attributed to the reduction of both cholesterol absorption and bile acids reabsorption in hamsters. J Agric Food Chem 2020,68(37),10003-10014","journal-title":"J Agric Food Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MOL.0000000000000626","volume":"30","author":"Hokkanen K.","year":"2019","unstructured":"Hokkanen K.; Tirronen A.; Yl&#xE4;-Herttuala S.; Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis. Curr Opin Lipidol 2019,30(5),370-376","journal-title":"Curr Opin Lipidol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aap9331","volume":"361","author":"Zhang F.","year":"2018","unstructured":"Zhang F.; Zarkada G.; Han J.; Li J.; Dubrac A.; Ola R.; Genet G.; Boy&#xE9; K.; Michon P.; K&#xFC;nzel S.E.; Camporez J.P.; Singh A.K.; Fong G.H.; Simons M.; Tso P.; Fern&#xE1;ndez-Hernando C.; Shulman G.I.; Sessa W.C.; Eichmann A.; Lacteal junction zippering protects against diet-induced obesity. Science 2018,361(6402),599-603","journal-title":"Science"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2012.09.039","volume":"225","author":"Kivel&#xE4; A.M.","year":"2012","unstructured":"Kivel&#xE4; A.M.; Dijkstra M.H.; Heinonen S.E.; Gurzeler E.; Jauhiainen S.; Levonen A.L.; Yl&#xE4;-Herttuala S.; Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A. Atherosclerosis 2012,225(2),335-340","journal-title":"Atherosclerosis"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells8121601","volume":"8","author":"Curtarello M.","year":"2019","unstructured":"Curtarello M.; Tognon M.; Venturoli C.; Silic-Benussi M.; Grassi A.; Verza M.; Minuzzo S.; Pinazza M.; Brillo V.; Tosi G.; Ferrazza R.; Guella G.; Iorio E.; Godfroid A.; Sounni N.E.; Amadori A.; Indraccolo S.; Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy. Cells 2019,8(12),8","journal-title":"Cells"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"Ferrara N.","year":"2004","unstructured":"Ferrara N.; Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 2004,25(4),581-611","journal-title":"Endocr Rev"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.18632\/aging.101726","volume":"11","author":"Jin F.","year":"2019","unstructured":"Jin F.; Zheng X.; Yang Y.; Yao G.; Ye L.; Doeppner T.R.; Hermann D.M.; Wang H.; Dai Y.; Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNF&#x3B1; and angiogenic VEGF. Aging (Albany NY) 2019,11(2),328-349","journal-title":"Aging (Albany NY)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"982458","DOI":"10.1155\/2013\/982458","volume":"2013","author":"Schlich R.","year":"2013","unstructured":"Schlich R.; Willems M.; Greulich S.; Ruppe F.; Knoefel W.T.; Ouwens D.M.; Maxhera B.; Lichtenberg A.; Eckel J.; Sell H.; VEGF in the crosstalk between human adipocytes and smooth muscle cells: Depot-specific release from visceral and perivascular adipose tissue. Mediators Inflamm 2013,2013,982458","journal-title":"Mediators Inflamm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.molmet.2018.02.004","volume":"11","author":"Sch&#xFC;ler R.","year":"2018","unstructured":"Sch&#xFC;ler R.; Seebeck N.; Osterhoff M.A.; Witte V.; Fl&#xF6;el A.; Busjahn A.; Jais A.; Br&#xFC;ning J.C.; Frahnow T.; Kabisch S.; Pivovarova O.; Hornemann S.; Kruse M.; Pfeiffer A.F.H.; VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans. Mol Metab 2018,11,129-136","journal-title":"Mol Metab"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nature06613","volume":"451","author":"Arany Z.","year":"2008","unstructured":"Arany Z.; Foo S.Y.; Ma Y.; Ruas J.L.; Bommi-Reddy A.; Girnun G.; Cooper M.; Laznik D.; Chinsomboon J.; Rangwala S.M.; Baek K.H.; Rosenzweig A.; Spiegelman B.M.; HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 2008,451(7181),1008-1012","journal-title":"Nature"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"110791","DOI":"10.1016\/j.nut.2020.110791","volume":"78","author":"Miranda C.S.","year":"2020","unstructured":"Miranda C.S.; Silva-Veiga F.; Martins F.F.; Rachid T.L.; Mandarim-De-Lacerda C.A.; Souza-Mello V.; PPAR-&#x3B1; activation counters brown adipose tissue whitening: A comparative study between high-fat- and high-fructose-fed mice. Nutrition 2020,78,110791","journal-title":"Nutrition"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mce.2015.02.012","volume":"406","author":"Hasan A.U.","year":"2015","unstructured":"Hasan A.U.; Ohmori K.; Konishi K.; Igarashi J.; Hashimoto T.; Kamitori K.; Yamaguchi F.; Tsukamoto I.; Uyama T.; Ishihara Y.; Noma T.; Tokuda M.; Kohno M.; Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPAR&#x3B3; mediated pathways in 3T3-L1 adipocytes. Mol Cell Endocrinol 2015,406,10-18","journal-title":"Mol Cell Endocrinol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jcb.24988","volume":"116","author":"Zingg J.M.","year":"2015","unstructured":"Zingg J.M.; Azzi A.; Meydani M.; Induction of VEGF expression by alpha-tocopherol and alpha-tocopheryl phosphate via PI3K&#x3B3;\/PKB and hTAP1\/SEC14L2-mediated lipid exchange. J Cell Biochem 2015,116(3),398-407","journal-title":"J Cell Biochem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22020798","volume":"22","author":"Zabroski I.O.","year":"2021","unstructured":"Zabroski I.O.; Nugent M.A.; Lipid Raft Association Stabilizes VEGF Receptor 2 in Endothelial Cells. Int J Mol Sci 2021,22(2),22","journal-title":"Int J Mol Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.biopha.2017.01.074","volume":"88","author":"Wei G.","year":"2017","unstructured":"Wei G.; Yin Y.; Duan J.; Guo C.; Zhu Y.; Wang Y.; Xi M.; Wen A.; Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1\/VEGF-A\/SDF-1&#x3B1; cascade. Biomed Pharmacother 2017,88,409-420","journal-title":"Biomed Pharmacother"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1111\/jcmm.13552","volume":"22","author":"Zou J.","year":"2018","unstructured":"Zou J.; Wang N.; Liu M.; Bai Y.; Wang H.; Liu K.; Zhang H.; Xiao X.; Wang K.; Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9. J Cell Mol Med 2018,22(5),2692-2705","journal-title":"J Cell Mol Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"113475","DOI":"10.1016\/j.jep.2020.113475","volume":"267","author":"Zhai S.","year":"2021","unstructured":"Zhai S.; Zhang X.F.; Lu F.; Chen W.G.; He X.; Zhang C.F.; Wang C.Z.; Yuan C.S.; Chinese medicine GeGen-DanShen extract protects from myocardial ischemic injury through promoting angiogenesis via up-regulation of VEGF\/VEGFR2 signaling pathway. J Ethnopharmacol 2021,267,113475","journal-title":"J Ethnopharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2009.01.046","volume":"607","author":"Zhang J.","year":"2009","unstructured":"Zhang J.; Liu A.; Hou R.; Zhang J.; Jia X.; Jiang W.; Chen J.; Salidroside protects cardiomyocyte against hypoxia-induced death: A HIF-1alpha-activated and VEGF-mediated pathway. Eur J Pharmacol 2009,607(1-3),6-14","journal-title":"Eur J Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/19336918.2017.1379634","volume":"12","author":"Zhu H.","year":"2018","unstructured":"Zhu H.; Gao M.; Gao X.; Tong Y.; Vascular endothelial growth factor-B: Impact on physiology and pathology. Cell Adhes Migr 2018,12(3),215-227","journal-title":"Cell Adhes Migr"},{"key":"ref=68","first-page":"225","volume":"28","author":"Sun C.Y.","year":"2014","unstructured":"Sun C.Y.; Lee C.C.; Hsieh M.F.; Chen C.H.; Chou K.M.; Clinical association of circulating VEGF-B levels with hyperlipidemia and target organ damage in type 2 diabetic patients. J Biol Regul Homeost Agents 2014,28(2),225-236","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.jcjd.2017.10.019","volume":"42","author":"Mancini G.B.J.","year":"2018","unstructured":"Mancini G.B.J.; Hegele R.A.; Leiter L.A.; Dyslipidemia. Can J Diabetes 2018,42(Suppl. 1),S178-S185","journal-title":"Can J Diabetes"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"E1031","DOI":"10.1152\/ajpendo.00090.2020","volume":"319","author":"Lu X.","year":"2020","unstructured":"Lu X.; Hu S.; Liao Y.; Zheng J.; Zeng T.; Zhong X.; Liu G.; Gou L.; Chen L.; Vascular endothelial growth factor B promotes transendothelial fatty acid transport into skeletal muscle via histone modifications during catch-up growth. Am J Physiol Endocrinol Metab 2020,319(6),E1031-E1043","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature08945","volume":"464","author":"Hagberg C.E.","year":"2010","unstructured":"Hagberg C.E.; Falkevall A.; Wang X.; Larsson E.; Huusko J.; Nilsson I.; van Meeteren L.A.; Samen E.; Lu L.; Vanwildemeersch M.; Klar J.; Genove G.; Pietras K.; Stone-Elander S.; Claesson-Welsh L.; Yl&#xE4;-Herttuala S.; Lindahl P.; Eriksson U.; Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 2010,464(7290),917-921","journal-title":"Nature"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"119401","DOI":"10.1016\/j.lfs.2021.119401","volume":"276","author":"Hu L.","year":"2021","unstructured":"Hu L.; Shan Z.; Wang F.; Gao X.; Tong Y.; Vascular endothelial growth factor B exerts lipid-lowering effect by activating AMPK via VEGFR1. Life Sci 2021,276,119401","journal-title":"Life Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1161\/CIRCRESAHA.108.178459","volume":"103","author":"Karpanen T.","year":"2008","unstructured":"Karpanen T.; Bry M.; Ollila H.M.; Sepp&#xE4;nen-Laakso T.; Liimatta E.; Leskinen H.; Kivel&#xE4; R.; Helkamaa T.; Merentie M.; Jeltsch M.; Paavonen K.; Andersson L.C.; Mervaala E.; Hassinen I.E.; Yl&#xE4;-Herttuala S.; Oresic M.; Alitalo K.; Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res 2008,103(9),1018-1026","journal-title":"Circ Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/08977194.2019.1626851","volume":"37","author":"Li L.J.","year":"2019","unstructured":"Li L.J.; Ma J.; Li S.B.; Chen X.; Zhang J.; Vascular endothelial growth factor B inhibits lipid accumulation in C2C12 myotubes incubated with fatty acids. Growth Factors 2019,37(1-2),76-84","journal-title":"Growth Factors"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41598-020-57599-2","volume":"10","author":"Ning F.C.","year":"2020","unstructured":"Ning F.C.; Jensen N.; Mi J.; Lindstr&#xF6;m W.; Balan M.; Muhl L.; Eriksson U.; Nilsson I.; Nyqvist D.; VEGF-B ablation in pancreatic &#x3B2;-cells upregulates insulin expression without affecting glucose homeostasis or islet lipid uptake. Sci Rep 2020,10(1),923","journal-title":"Sci Rep"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cmet.2017.01.004","volume":"25","author":"Falkevall A.","year":"2017","unstructured":"Falkevall A.; Mehlem A.; Palombo I.; Heller Sahlgren B.; Ebarasi L.; He L.; Ytterberg A.J.; Olauson H.; Axelsson J.; Sundelin B.; Patrakka J.; Scotney P.; Nash A.; Eriksson U.; Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease. Cell Metab 2017,25(3),713-726","journal-title":"Cell Metab"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.apsb.2020.07.002","volume":"11","author":"Shen Y.","year":"2021","unstructured":"Shen Y.; Chen W.; Han L.; Bian Q.; Fan J.; Cao Z.; Jin X.; Ding T.; Xian Z.; Guo Z.; Zhang W.; Ju D.; Mei X.; VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharm Sin B 2021,11(1),127-142","journal-title":"Acta Pharm Sin B"},{"key":"ref=78","first-page":"1186","volume":"19","author":"Ye X.","year":"2020","unstructured":"Ye X.; Kong W.; Zafar M.I.; Zeng J.; Yang R.; Chen L.L.; Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction. EXCLI J 2020,19,1186-1195","journal-title":"EXCLI J"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"e49343","DOI":"10.15252\/embr.201949343","volume":"21","author":"Moessinger C.","year":"2020","unstructured":"Moessinger C.; Nilsson I.; Muhl L.; Zeitelhofer M.; Heller Sahlgren B.; Skogsberg J.; Eriksson U.; VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content. EMBO Rep 2020,21(7),e49343","journal-title":"EMBO Rep"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1530\/JOE-19-0341","volume":"244","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Zhao M.; Wang C.; Wen H.; Zhang Y.; Lu M.; Adlat S.; Zheng T.; Zhang M.; Li D.; Lu X.; Guo M.; Chen H.; Zhang L.; Feng X.; Zheng Y.; Adipose vascular endothelial growth factor B is a major regulator of energy metabolism. J Endocrinol 2020,244(3),511-521","journal-title":"J Endocrinol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"17114","DOI":"10.18632\/aging.103649","volume":"12","author":"Liu X.","year":"2020","unstructured":"Liu X.; He Y.; Feng Z.; Sheng J.; Dong A.; Zhang M.; Cao L.; miR-345-5p regulates adipogenesis via targeting VEGF-B. Aging (Albany NY) 2020,12(17),17114-17121","journal-title":"Aging (Albany NY)"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2337\/db15-1231","volume":"65","author":"Mehlem A.","year":"2016","unstructured":"Mehlem A.; Palombo I.; Wang X.; Hagberg C.E.; Eriksson U.; Falkevall A.; PGC-1&#x3B1; Coordinates Mitochondrial Respiratory Capacity and Muscular Fatty Acid Uptake via Regulation of VEGF-B. Diabetes 2016,65(4),861-873","journal-title":"Diabetes"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000491775","volume":"48","author":"Lv Y.X.","year":"2018","unstructured":"Lv Y.X.; Zhong S.; Tang H.; Luo B.; Chen S.J.; Chen L.; Zheng F.; Zhang L.; Wang L.; Li X.Y.; Yan Y.W.; Pan Y.M.; Jiang M.; Zhang Y.E.; Wang L.; Yang J.Y.; Guo L.Y.; Chen S.Y.; Wang J.N.; Tang J.M.; VEGF-A and VEGF-B Coordinate the Arteriogenesis to Repair the Infarcted Heart with Vagus Nerve Stimulation. Cell Physiol Biochem 2018,48(2),433-449","journal-title":"Cell Physiol Biochem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/10715762.2018.1554901","volume":"53","author":"Feng L.","year":"2019","unstructured":"Feng L.; Ren J.; Li Y.; Yang G.; Kang L.; Zhang S.; Ma C.; Li J.; Liu J.; Yang L.; Qi Z.; Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B\/AMPK\/eNOS\/NO signalling pathway. Free Radic Res 2019,53(1),82-93","journal-title":"Free Radic Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/cen.12950","volume":"84","author":"Cheng F.","year":"2016","unstructured":"Cheng F.; Zhao L.; Wu Y.; Huang T.; Yang G.; Zhang Z.; Wu Y.; Jia F.; Wu J.; Chen C.; Liu D.; Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment. Clin Endocrinol (Oxf) 2016,84(3),386-393","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.jnutbio.2019.01.018","volume":"79","author":"Tian W.","year":"2020","unstructured":"Tian W.; Yang L.; Liu Y.; He J.; Yang L.; Zhang Q.; Liu F.; Li J.; Liu J.; Sumi S.; Shen Y.; Qi Z.; Resveratrol attenuates doxorubicin-induced cardiotoxicity in rats by up-regulation of vascular endothelial growth factor B. J Nutr Biochem 2020,79,108132","journal-title":"J Nutr Biochem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.15252\/emmm.201505731","volume":"7","author":"Nurmi H.","year":"2015","unstructured":"Nurmi H.; Saharinen P.; Zarkada G.; Zheng W.; Robciuc M.R.; Alitalo K.; VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption. EMBO Mol Med 2015,7(11),1418-1425","journal-title":"EMBO Mol Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3389\/fphys.2018.01783","volume":"9","author":"Shew T.","year":"2018","unstructured":"Shew T.; Wolins N.E.; Cifarelli V.; VEGFR-3 Signaling Regulates Triglyceride Retention and Absorption in the Intestine. Front Physiol 2018,9,1783","journal-title":"Front Physiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molmet.2014.11.006","volume":"4","author":"Karaman S.","year":"2014","unstructured":"Karaman S.; Hollm&#xE9;n M.; Robciuc M.R.; Alitalo A.; Nurmi H.; Morf B.; Buschle D.; Alkan H.F.; Ochsenbein A.M.; Alitalo K.; Wolfrum C.; Detmar M.; Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet. Mol Metab 2014,4(2),93-105","journal-title":"Mol Metab"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"31566","DOI":"10.1038\/srep31566","volume":"6","author":"Karaman S.","year":"2016","unstructured":"Karaman S.; Hollm&#xE9;n M.; Yoon S.Y.; Alkan H.F.; Alitalo K.; Wolfrum C.; Detmar M.; Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice. Sci Rep 2016,6(1),31566","journal-title":"Sci Rep"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/ATVBAHA.114.302528","volume":"34","author":"Vuorio T.","year":"2014","unstructured":"Vuorio T.; Nurmi H.; Moulton K.; Kurkipuro J.; Robciuc M.R.; Ohman M.; Heinonen S.E.; Samaranayake H.; Heikura T.; Alitalo K.; Yl&#xE4;-Herttuala S.; Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis. Arterioscler Thromb Vasc Biol 2014,34(6),1162-1170","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"e94713","DOI":"10.1371\/journal.pone.0094713","volume":"9","author":"Blum K.S.","year":"2014","unstructured":"Blum K.S.; Karaman S.; Proulx S.T.; Ochsenbein A.M.; Luciani P.; Leroux J.C.; Wolfrum C.; Detmar M.; Chronic high-fat diet impairs collecting lymphatic vessel function in mice. PLoS One 2014,9(4),e94713","journal-title":"PLoS One"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2020.02.154","volume":"525","author":"Park M.","year":"2020","unstructured":"Park M.; Cho K.A.; Kim Y.H.; Lee K.H.; Woo S.Y.; Lymphatic endothelial cells promote T lymphocyte migration into lymph nodes under hyperlipidemic conditions. Biochem Biophys Res Commun 2020,525(3),786-792","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.mvr.2006.05.009","volume":"72","author":"Rutkowski J.M.","year":"2006","unstructured":"Rutkowski J.M.; Moya M.; Johannes J.; Goldman J.; Swartz M.A.; Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 2006,72(3),161-171","journal-title":"Microvasc Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1096\/fj.201500112","volume":"30","author":"Taher M.","year":"2016","unstructured":"Taher M.; Nakao S.; Zandi S.; Melhorn M.I.; Hayes K.C.; Hafezi-Moghadam A.; Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: A regulatory role for soluble VEGF receptor 2. FASEB J 2016,30(7),2490-2499","journal-title":"FASEB J"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1159\/000494177","volume":"50","author":"Huang Y.L.","year":"2018","unstructured":"Huang Y.L.; Lin Y.C.; Lin C.C.; Chen W.M.; Chen B.P.C.; Lee H.; High Glucose Induces VEGF-C Expression via the LPA1\/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells. Cell Physiol Biochem 2018,50(2),597-611","journal-title":"Cell Physiol Biochem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1080\/10641963.2017.1324478","volume":"39","author":"Yang G.H.","year":"2017","unstructured":"Yang G.H.; Zhou X.; Ji W.J.; Liu J.X.; Sun J.; Dong Y.; Jiang T.M.; Li Y.M.; VEGF-C-mediated cardiac lymphangiogenesis in high salt intake accelerated progression of left ventricular remodeling in spontaneously hypertensive rats. Clin Exp Hypertens 2017,39(8),740-747","journal-title":"Clin Exp Hypertens"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/ATVBAHA.110.222356","volume":"31","author":"Hosono K.","year":"2011","unstructured":"Hosono K.; Suzuki T.; Tamaki H.; Sakagami H.; Hayashi I.; Narumiya S.; Alitalo K.; Majima M.; Roles of prostaglandin E2-EP3\/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation. Arterioscler Thromb Vasc Biol 2011,31(5),1049-1058","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1172\/jci.insight.93887","volume":"2","author":"Tatin F.","year":"2017","unstructured":"Tatin F.; Renaud-Gabardos E.; Godet A.C.; Hantelys F.; Pujol F.; Morfoisse F.; Calise D.; Viars F.; Valet P.; Masri B.; Prats A.C.; Garmy-Susini B.; Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction. JCI Insight 2017,2(12),2","journal-title":"JCI Insight"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0930-x","volume":"18","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Wang D.; Peng H.; Chen X.; Han X.; Yu J.; Wang W.; Liang L.; Liu Z.; Zheng Y.; Hu J.; Yang L.; Li J.; Zhou H.; Cui X.; Li F.; Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLC&#x3B5;-NF-&#x3BA;B signaling pathway and VEGF-C\/Bcl-2 expression. Mol Cancer 2019,18(1),1","journal-title":"Mol Cancer"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.cellsig.2008.06.008","volume":"20","author":"Lin C.I.","year":"2008","unstructured":"Lin C.I.; Chen C.N.; Huang M.T.; Lee S.J.; Lin C.H.; Chang C.C.; Lee H.; Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1\/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms. Cell Signal 2008,20(10),1804-1814","journal-title":"Cell Signal"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"73711","DOI":"10.18632\/oncotarget.12449","volume":"7","author":"Zhu G.","year":"2016","unstructured":"Zhu G.; Huang Q.; Huang Y.; Zheng W.; Hua J.; Yang S.; Zhuang J.; Wang J.; Ye J.; Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-&#x3BA;B\/JNK pathways in colorectal cancer. Oncotarget 2016,7(45),73711-73724","journal-title":"Oncotarget"},{"key":"ref=103","first-page":"572","volume":"54","author":"Ma C.","year":"2019","unstructured":"Ma C.; Xie J.; Luo C.; Yin H.; Li R.; Wang X.; Xiong W.; Zhang T.; Jiang P.; Qi W.; Zhou T.; Yang Z.; Wang W.; Ma J.; Gao G.; Yang X.; OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF-C expression and secretion. Int J Oncol 2019,54(2),572-584","journal-title":"Int J Oncol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41419-019-1436-1","volume":"10","author":"Hwang S.D.","year":"2019","unstructured":"Hwang S.D.; Song J.H.; Kim Y.; Lim J.H.; Kim M.Y.; Kim E.N.; Hong Y.A.; Chung S.; Choi B.S.; Kim Y.S.; Park C.W.; Inhibition of lymphatic proliferation by the selective VEGFR-3 inhibitor SAR131675 ameliorates diabetic nephropathy in db\/db mice. Cell Death Dis 2019,10(3),219","journal-title":"Cell Death Dis"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1038\/s41467-021-23808-3","volume":"12","author":"Cifarelli V.","year":"2021","unstructured":"Cifarelli V.; Appak-Baskoy S.; Peche V.S.; Kluzak A.; Shew T.; Narendran R.; Pietka K.M.; Cella M.; Walls C.W.; Czepielewski R.; Ivanov S.; Randolph G.J.; Augustin H.G.; Abumrad N.A.; Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells. Nat Commun 2021,12(1),3350","journal-title":"Nat Commun"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-007-9624-1","volume":"308","author":"Sun P.","year":"2008","unstructured":"Sun P.; Gao J.; Liu Y.L.; Wei L.W.; Wu L.P.; Liu Z.Y.; RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells. Mol Cell Biochem 2008,308(1-2),161-168","journal-title":"Mol Cell Biochem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2020.04.021","volume":"488","author":"Yan S.","year":"2020","unstructured":"Yan S.; Wang H.; Chen X.; Liang C.; Shang W.; Wang L.; Li J.; Xu D.; MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Cancer Lett 2020,488,18-26","journal-title":"Cancer Lett"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.3892\/mmr.2016.5920","volume":"14","author":"Cai F.","year":"2016","unstructured":"Cai F.; Li J.; Liu Y.; Zhang Z.; Hettiarachchi D.S.; Li D.; Effect of ximenynic acid on cell cycle arrest and apoptosis and COX-1 in HepG2 cells. Mol Med Rep 2016,14(6),5667-5676","journal-title":"Mol Med Rep"},{"key":"ref=109","first-page":"1701","volume":"34","author":"Yamamura T.","year":"2014","unstructured":"Yamamura T.; Matsumoto N.; Matsue Y.; Okudera M.; Nishikawa Y.; Abiko Y.; Komiyama K.; Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3. Anticancer Res 2014,34(4),1701-1708","journal-title":"Anticancer Res"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1161\/ATVBAHA.118.311549","volume":"38","author":"Tirronen A.","year":"2018","unstructured":"Tirronen A.; Vuorio T.; Kettunen S.; Hokkanen K.; Ramms B.; Niskanen H.; Laakso H.; Kaikkonen M.U.; Jauhiainen M.; Gordts P.L.S.M.; Yl&#xE4;-Herttuala S.; Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants. Arterioscler Thromb Vasc Biol 2018,38(10),2327-2337","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.healun.2011.04.007","volume":"30","author":"Wong B.W.","year":"2011","unstructured":"Wong B.W.; Wong D.; Luo H.; McManus B.M.; Vascular endothelial growth factor-D is overexpressed in human cardiac allograft vasculopathy and diabetic atherosclerosis and induces endothelial permeability to low-density lipoproteins in vitro. J Heart Lung Transplant 2011,30(8),955-962","journal-title":"J Heart Lung Transplant"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.ajpath.2018.12.008","volume":"189","author":"Chakraborty A.","year":"2019","unstructured":"Chakraborty A.; Barajas S.; Lammoglia G.M.; Reyna A.J.; Morley T.S.; Johnson J.A.; Scherer P.E.; Rutkowski J.M.; Vascular Endothelial Growth Factor-D (VEGF-D) Overexpression and Lymphatic Expansion in Murine Adipose Tissue Improves Metabolism in Obesity. Am J Pathol 2019,189(4),924-939","journal-title":"Am J Pathol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"H384","DOI":"10.1152\/ajpheart.00208.2016","volume":"311","author":"Lammoglia G.M.","year":"2016","unstructured":"Lammoglia G.M.; Van Zandt C.E.; Galvan D.X.; Orozco J.L.; Dellinger M.T.; Rutkowski J.M.; Hyperplasia, de novo lymphangiogenesis, and lymphatic regression in mice with tissue-specific, inducible overexpression of murine VEGF-D. Am J Physiol Heart Circ Physiol 2016,311(2),H384-H394","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1096\/fj.05-5029fje","volume":"20","author":"Roy H.","year":"2006","unstructured":"Roy H.; Bhardwaj S.; Babu M.; Kokina I.; Uotila S.; Ahtialansaari T.; Laitinen T.; Hakumaki J.; Laakso M.; Herzig K.H.; Yl&#xE4;-Herttuala S.; Roy H.; Bhardwaj S.; Babu M.; Kokina I.; Uotila S.; Ahtialansaari T.; Laitinen T.; Hakumaki J.; Laakso M.; Herzig K-H.; Yl&#xE4;-Herttuala S.; VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J 2006,20(12),2159-2161","journal-title":"FASEB J"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1182\/blood-2008-12-196840","volume":"115","author":"Flister M.J.","year":"2010","unstructured":"Flister M.J.; Wilber A.; Hall K.L.; Iwata C.; Miyazono K.; Nisato R.E.; Pepper M.S.; Zawieja D.C.; Ran S.; Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 2010,115(2),418-429","journal-title":"Blood"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bbrc.2008.10.077","volume":"377","author":"Watari K.","year":"2008","unstructured":"Watari K.; Nakao S.; Fotovati A.; Basaki Y.; Hosoi F.; Bereczky B.; Higuchi R.; Miyamoto T.; Kuwano M.; Ono M.; Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 2008,377(3),826-831","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jcp.21315","volume":"215","author":"Mountain D.J.","year":"2008","unstructured":"Mountain D.J.; Singh M.; Singh K.; Downregulation of VEGF-D expression by interleukin-1beta in cardiac microvascular endothelial cells is mediated by MAPKs and PKCalpha\/beta1. J Cell Physiol 2008,215(2),337-343","journal-title":"J Cell Physiol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1248\/bpb.b19-00353","volume":"42","author":"Wang Q.","year":"2019","unstructured":"Wang Q.; Wang T.; Zhu L.; He N.; Duan C.; Deng W.; Zhang H.; Zhang X.; Sophocarpine Inhibits Tumorgenesis of Colorectal Cancer via Downregulation of MEK\/ERK\/VEGF Pathway. Biol Pharm Bull 2019,42(11),1830-1838","journal-title":"Biol Pharm Bull"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF02478931","volume":"19","author":"Sawa H.","year":"2002","unstructured":"Sawa H.; Murakami H.; Ohshima Y.; Murakami M.; Yamazaki I.; Tamura Y.; Mima T.; Satone A.; Ide W.; Hashimoto I.; Kamada H.; Histone deacetylase inhibitors such as sodium butyrate and trichostatin A inhibit vascular endothelial growth factor (VEGF) secretion from human glioblastoma cells. Brain Tumor Pathol 2002,19(2),77-81","journal-title":"Brain Tumor Pathol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"32027","DOI":"10.18632\/oncotarget.16757","volume":"8","author":"Song H.","year":"2017","unstructured":"Song H.; Lim D.Y.; Jung J.I.; Cho H.J.; Park S.Y.; Kwon G.T.; Kang Y.H.; Lee K.W.; Choi M.S.; Park J.H.Y.; Dietary oleuropein inhibits tumor angiogenesis and lymphangiogenesis in the B16F10 melanoma allograft model: A mechanism for the suppression of high-fat diet-induced solid tumor growth and lymph node metastasis. Oncotarget 2017,8(19),32027-32042","journal-title":"Oncotarget"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/MPA.0b013e31816705bc","volume":"36","author":"Pellizzaro C.","year":"2008","unstructured":"Pellizzaro C.; Speranza A.; Zorzet S.; Crucil I.; Sava G.; Scarlata I.; Cantoni S.; Fedeli M.; Coradini D.; Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: A preliminary report. Pancreas 2008,36(4),e15-e23","journal-title":"Pancreas"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220506105026","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204351\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220506105026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T13:00:55Z","timestamp":1677848455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204351\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201023666220506105026","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}